Literature DB >> 8199531

Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development.

G Passeri1, G Girasole, S C Manolagas, R L Jilka.   

Abstract

We have previously shown that tumor necrosis factor (TNF) and interleukin-1 (IL-1) acted synergistically to stimulate the production of IL-6 by bone marrow stromal and osteoblastic cells; and that an antibody to IL-6 inhibited TNF-induced osteoclast development in murine calvarial cell cultures. Prompted by this evidence, we have now examined whether TNF and/or IL-1 are produced by murine calvarial cells, and whether these cytokines are involved in IL-6 production and osteoclast formation. When cultured under basal conditions, calvarial cells produced TNF and IL-6, and were able to form bone resorbing osteoclasts. A neutralizing antibody against TNF suppressed both basal IL-6 production and the formation of bone resorbing osteoclasts. The anti-TNF antibody also inhibited IL-6 production in response to exogenous IL-1 or parathyroid hormone (PTH). In contrast, a neutralizing anti-IL-1 receptor antibody had no effect on basal, TNF- or PTH-stimulated IL-6 production. These findings suggest that TNF, but not IL-1, is produced by murine bone cells and that endogenous TNF induces the IL-6 production, osteoclast formation, and bone resorption exhibited by these cultures under basal conditions. Furthermore, bone cell-derived TNF amplifies the stimulatory effect of exogenous IL-1 or PTH on IL-6 production by calvarial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199531     DOI: 10.1016/s0169-6009(08)80149-3

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  3 in total

1.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Authors:  Y Abu-Amer; F P Ross; J Edwards; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Tumor necrosis factor-alpha mediates orthopedic implant osteolysis.

Authors:  K D Merkel; J M Erdmann; K P McHugh; Y Abu-Amer; F P Ross; S L Teitelbaum
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  Assessment of Serum Vitamin B12 Levels and Other Metabolic Parameters in Subjects With Different Values of Bone Mineral Density.

Authors:  Marianna Renis; Debora Lobreglio; Pierpaolo Congedo; Maria Concetta Montinaro; Maurizio Muratore; Giambattista Lobreglio
Journal:  J Clin Med Res       Date:  2018-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.